Current evidence suggests that demyelination may be a necessary but not a sufficient condition for neurologic deficits associated with multiple sclerosis. Axon injury that occurs within the permissive environment of the demyelinated lesion is better correlated with functional deficits, but the mechanisms and cellular effectors of this injury are largely unknown. In an effort to identify potential axon injury mediators, we examined demyelination, motor function, and the number of spinal axons in perforin-deficient mice. Perforin is a critical molecular mediator of cytotoxic immunological injury and we hypothesized that genetic deletion of perforin expression would protect demyelinated axons. Indeed, we found that while perforin-deficient mice had considerable spinal cord demyelination 180 days after infection with Theiler's murine encephalomyelitis virus, such mice exhibited functional and axonal preservation comparable to nondemyelinated perforin-competent controls. We conclude that perforindependent effector cells such as cytotoxic T cells, γδ T cells, and natural killer cells may play a role in axon damage that is dependent upon but separable from demyelination.
Introduction
Demyelination of the central nervous system (CNS) is a pathological hallmark of multiple sclerosis (MS). The majority of efforts seeking to ameliorate the functional deficits associated with MS focus upon resolution or repair of the demyelinating insult. Such a therapeutic focus presupposes that demyelination is the primary basis for the functional deficit. Indeed, early studies demonstrated that CNS demyelination resulted in the slowing of axon conduction velocity as well as complete blockade of axon conduction (McDonald and Sears, 1969) , and such observations were generally considered sufficient to explain the majority of neurological dysfunction in MS patients. However, several clinical and basic science observations challenge this hypothesis. Magnetic resonance imaging studies have demonstrated only a weak correlation between lesion load and clinical deficit in MS patients (Stevens et al., 1986) , even though pathologically such lesions were indeed demyelinated (Bruck et al., 1997) and frequently involved areas of CNS expected to result in neurologic deficits. Autopsy studies have likewise demonstrated diagnostically relevant demyelination in individuals who exhibited normal neurologic function throughout their life (Mews et al., 1998) . These observations suggest that demyelination alone is insufficient to cause permanent neurologic deficit.
Animal experiments have also questioned the direct relationship between functional deficit and demyelination. Using a viral model of MS, we showed that β2-microglobulin-deficient experienced profound demyelination of the spinal cord but exhibited normal motor function (Rivera-Quinones et al., 1998), implicating surface expression of major histocompatibility complex (MHC) class I molecules in axon injury. Likewise, while retrograde labeling experiments demonstrated a failure of axonal transport in mice with demyelination and functional deficits (Ure and Rodriguez, 2000), we found preservation of axonal transport in demyelinated mice lacking β2-microglobulin (Ure and Rodriguez, 2002). In addition, specific peptide-mediated depletion of CD8+ class Irestricted cytotoxic T cells (CTLs) in animals infected with Theiler's murine encephalomyelitis virus (TMEV) resulted in preservation of neurologic function (Johnson et al., 2001) , suggesting a direct relationship between T cell-mediated killing and axon dropout. In support of this hypothesis, CD8+ T cells have been shown to injure neurons and transect axons in vitro (Medana et al., 2001) . With regard to human MS, recent pathology studies indicate that CD8+ T cells may be the most common subset of T cells in the MS brain (Babbe et al., 2000) and autopsy studies demonstrate that CD8+ T cells are frequently associated with axonal injury in MS (Bitsch et al., 2000) . Moreover, demyelination 
